Sweden: Ekman to replace Lindholm as CEO at Bluefish Pharmaceuticals

Erik Ekman is to take on the role of CEO at Bluefish Pharmaceuticals during spring 2022 in the wake of Berit Lindholm, the current CEO, deciding to leave the company for a non-competitive organisation. Ekman currently holds the COO position in the company, a position he has held for the last four years. He previously…

You must be a HMI Subscriber to view this content.

Login » Subscribe Now »

Advertisement